comparemela.com

Latest Breaking News On - Purified cortrophin gel - Page 1 : comparemela.com

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

29.05.2024 - BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New .

Pharmaceuticals incRare diseasePurified cortrophin gelEstablished brands

ANI Pharmaceuticals Announces the Launch of Kionex Suspension

ANI Pharmaceuticals Announces the Launch of Kionex Suspension
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Pharmaceuticals incSodium polystyrene sulfonate oralRectal suspensionRare diseasePurified cortrophin gelEstablished brands

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Red seaDjibouti generalIsrael generalLisam wilsonRevenues for the companySite communications incPharmaceuticals incExchange commissionNet revenue total companyEstablished brandsServing patientsImproving livesRecent business highlightsCortrophin gelRare diseaseCompetitive generic therapy

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

01.05.2024 - BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two .

New yorkUnited statesStephen careyNikhil lalwaniPharmaceuticals incCompany nasdaqCapital oneChief executive officerChief financial officerNew york cityBiopharma disruptorsAnnual bioconnect conferenceRare diseasePurified cortrophin gelAni pharmaceuticals chartNi pharmaceuticals kurs

ANI Pharmaceuticals Inc (ANIP) Reports Strong Growth in Q4 and Full-Year 2023, Sets Positive

ANI Pharmaceuticals Announces Record Revenue and EBITDA, Driven by Rare Disease Business and Operational Excellence

Nikhil lalwaniPharmaceuticals incFinancial highlightsCompetitive generic therapyPurified cortrophin gelRare diseaseCortrophin gel

vimarsana © 2020. All Rights Reserved.